Kinstellar, Soltysinski Kawecki & Szlezak, and Cobalt have advised Stada Arzneimittel on the acquisition of Walmark from Mid Europa Partners. White & Case and Weil, Gotshal & Manges reportedly advised the sellers on the deal.
The transaction is subject to customary anti-trust clearance and is expected to close in the first quarter of 2020. Financial details were not disclosed.
Mid Europa acquired 50% of Walmark in 2012 and the remainder in 2015 (as reported by CEE Legal Matters on October 20, 2015). Walmark is a Central European manufacturer of consumer health products that has a direct presence in the Czech Republic, Slovakia, Poland, Hungary, Bulgaria, Romania, Lithuania, Latvia, and Estonia, and that sells its products in more than 40 countries worldwide.
The Kinstellar team was co-led by Partner Anthony O'Connor from Budapest and Partner Lukas Sevcik and Counsel Karla Rundtova from Prague.
Editor's Note: After this article was published Cobalt announced that its team providing Baltic assistance to Stada was led by Estonia-based Partner Martin Simovart and Senior Associate Madis Reppo, working with Partner Elo Tamm, Associate Marit Martens and Associate Tiit-Gregor Mets in Estonia, Partner Guntars Zile, Senior Associates Elina Locmele, Ugis Zeltiņs and Kristine Patmalniece, and Associate Diana Zepa in Latvia, and Partners Juozas Rimas and Rasa Zasciurinskaite and Associates Julija Timoscenko and Samanta Sereikaite in Lithuania.
Subsequently, in March 2020, Kinstellar announced that the deal had successfully closed.